SCHEMBL24506812

SCHEMBL24506812

CCc1ccc2cnc(N)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHFR P00374 2/20 0.45
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ CSNK1D P48730 1/20 0.44
▸ CSNK1E P49674 1/20 0.44
▸ CLK1 P49759 1/20 0.44
▸ DYRK1A Q13627 1/20 0.44
▸ MAP3K14 Q99558 1/20 0.43
▸ NOS3 P29474 2/20 0.43
▸ NOS1 P29475 2/20 0.43
▸ NOS2 P35228 1/20 0.43
▸ KCNH2 Q12809 3/20 0.43
▸ HRH4 Q9H3N8 3/20 0.43
▸ HRH3 Q9Y5N1 3/20 0.43
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4572162 0.86 LCK (0.49) DHFRNPC1RAB9ASMN1; SMN2CSNK1D
SCHEMBL4416698 0.84 NOS1 (0.46) CSNK1DCSNK1ECLK1DYRK1ANOS1
SCHEMBL22521514 0.81 CSNK1D (0.41) DHFRCSNK1DCSNK1ECLK1DYRK1A
SCHEMBL22521442 0.81 CSNK1D (0.41) DHFRCSNK1DCSNK1ECLK1DYRK1A
SCHEMBL24506863 0.76 KCNH2 (0.47) DHFRNPC1RAB9ASMN1; SMN2NOS3
SCHEMBL26955899 0.76 CYP1A2 (0.39) NPC1RAB9ASMN1; SMN2NOS3NOS1
SCHEMBL22449721 0.76 CYP1A2 (0.50) CSNK1DCSNK1ECLK1DYRK1AHRH4
SCHEMBL7046423 0.76 NOS1 (0.56) NOS3NOS1NOS2
SCHEMBL7729942 0.75 RAB9A (0.44) NPC1RAB9ASMN1; SMN2MAP3K14NOS3
SCHEMBL24150165 0.75 HTT (0.58) SMN1; SMN2CSNK1DCSNK1ECLK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2023-07-06 — — US disclosed
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2022-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185792-A1 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 DHFR 1550/4885NPC1 2525/4885RAB9A 1027/4885
US-20230212143-A9 PRMT5 INHIBITOR COMPOUNDS PRMT5, PRMT1, PRMT6 DHFR 1550/4885NPC1 2525/4885RAB9A 1027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback